CASI Pharmaceuticals (CASI) Interest & Investment Income (2022 - 2025)
Historic Interest & Investment Income for Pharmaceuticals (CASI) over the last 4 years, with Q2 2025 value amounting to $45000.0.
- Pharmaceuticals' Interest & Investment Income fell 6666.67% to $45000.0 in Q2 2025 from the same period last year, while for Jun 2025 it was $388000.0, marking a year-over-year decrease of 2996.39%. This contributed to the annual value of $539000.0 for FY2024, which is 1430.84% down from last year.
- Latest data reveals that Pharmaceuticals reported Interest & Investment Income of $45000.0 as of Q2 2025, which was down 6666.67% from $77000.0 recorded in Q1 2025.
- Pharmaceuticals' Interest & Investment Income's 5-year high stood at $161000.0 during Q3 2023, with a 5-year trough of -$13000.0 in Q3 2022.
- Moreover, its 4-year median value for Interest & Investment Income was $107500.0 (2022), whereas its average is $93875.0.
- As far as peak fluctuations go, Pharmaceuticals' Interest & Investment Income soared by 133846.15% in 2023, and later plummeted by 6666.67% in 2025.
- Over the past 4 years, Pharmaceuticals' Interest & Investment Income (Quarter) stood at $88000.0 in 2022, then soared by 44.32% to $127000.0 in 2023, then grew by 6.3% to $135000.0 in 2024, then plummeted by 66.67% to $45000.0 in 2025.
- Its Interest & Investment Income stands at $45000.0 for Q2 2025, versus $77000.0 for Q1 2025 and $135000.0 for Q2 2024.